Related Experiment Video
Updated: Jul 6, 2025

08:00
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
Published on: May 14, 2015
31.7K
Stochastic biological system-of-systems modelling for iPSC culture
Hua Zheng1, Sarah W Harcum2, Jinxiang Pei1
1Mechanical and Industrial Engineering, Northeastern University, Boston, MA, 02115, USA.
Communications Biology
|January 8, 2024
Summary
Manufacturing induced pluripotent stem cells (iPSCs) is challenging due to cell aggregation. A new Biological System-of-Systems (Bio-SoS) model addresses nutrient and waste issues in iPSC cultures, improving cell therapy production.
Area of Science:
- Biotechnology
- Cell Biology
- Bioengineering
Background:
- Large-scale manufacturing of induced pluripotent stem cells (iPSCs) is crucial for advancing cell therapies and regenerative medicine.
- iPSCs aggregate in suspension bioreactors, leading to nutrient deprivation and waste accumulation in core cells.
- Micro-environmental variations can cause significant heterogeneity within iPSC populations.
Purpose of the Study:
- To develop a novel Biological System-of-Systems (Bio-SoS) framework for modeling iPSC aggregation and micro-environmental effects.
- To characterize cell-to-cell interactions, spatial and metabolic heterogeneity, and cellular responses to environmental changes.
- To provide a predictive model for optimizing large-scale iPSC manufacturing processes.
Main Methods:
- Developed a Bio-SoS model integrating stochastic metabolic reaction networks, aggregation kinetics, and reaction-diffusion mechanisms.
- Modeled causal interdependencies at the cellular, aggregate, and population levels.
- Incorporated a modular design for data integration across different culture systems (monolayer and aggregate).
Main Results:
- The Bio-SoS model effectively characterizes cell-to-cell interactions and heterogeneity within iPSC aggregates.
- The framework quantifies the impact of factors like aggregate size on cell health and product quality.
- Demonstrated improved predictions for both monolayer and aggregate iPSC culture processes.
Conclusions:
- The proposed Bio-SoS framework offers a robust approach to understanding and mitigating heterogeneity in large-scale iPSC manufacturing.
- This modeling strategy can guide the optimization of bioreactor conditions to enhance cell product quality for therapeutic applications.
- The variance decomposition analysis provides critical insights into factors influencing cell quality heterogeneity.
Related Concept Videos
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K

